Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Rosemary R. Berardi"'
Autor:
Rosemary R. Berardi
Publikováno v:
Journal of the American Pharmacists Association. 44:41-51
Objectives To discuss the need for safe and effective therapy for patients with irritable bowel syndrome (IBS) and to provide up-to-date information on the safety and tolerability profile of tegaserod, a novel treatment for women with IBS whose prima
Autor:
Roger S. Klotz, Ewan McNicol, Sujit S. Sansgiry, Gauri S. Shringarpure, Janice L. Stumpf, Paul C. Walker, Rosemary R. Berardi, Leonard L. Kaplan
Publikováno v:
Journal of the American Pharmacists Association. 43:342-346
Autor:
Rosemary R. Berardi, Lynda S. Welage
Publikováno v:
American Journal of Health-System Pharmacy. 55:2289-2298
Autor:
Rosemary R. Berardi
Publikováno v:
Journal of Pharmaceutical Care in Pain & Symptom Control. 5:57-64
Major advances in the pharmacotherapy of gastrointestinal and hepatic disorders have occurred in recent years. Important adverse effects on the GI tract due to symptom control medications and on other systems due to GI drugs also have been identified
Autor:
George J. Brewer, Sahar Z. Swidan, Jennifer B. Dressman, Constance H. Adair, Lisa M. Henderson, Daniel J. DuRoss, Rosemary R. Berardi, Jeffrey L. Barnett
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 19:393-397
Zinc is an important nutrient and is necessary to maintain a multitude of physiologic processes. Mineral supplements that provide physiologic doses of zinc may be used when dietary zinc is inadequate. Zinc is also used in pharmacologic doses to treat
Autor:
Grace H. Elta, Valerie A. Dunn-Kucharski, David Smith, Jyoti K. Paliwal, Rosemary R. Berardi, Steven R. Cox
Publikováno v:
Biopharmaceutics & Drug Disposition. 15:545-561
The stereoselective disposition and metabolic inversion of ibuprofen were studied in 12 healthy subjects under conditions of competitive and non-linear plasma protein binding. Each subject received each of four oral treatments according to a Latin-sq
Autor:
Lynda S. Welage, Rosemary R. Berardi
Publikováno v:
Journal of Pharmacy Practice. 7:165-176
Proton pump inhibitors represent an important advance in the treatment of acid-peptic disease. Omeprazole, the prototype of the drug class, produces a profound and sustained degree of gastric acid suppression. Recent studies confirm earlier reports t
Autor:
Rosemary R. Berardi, Jennifer B. Dressman, Jeffrey L. Barnett, Tami L. O’Sullivan, Tanya L. Russell, John G. Wagner
Publikováno v:
Pharmaceutical Research. 11:136-143
The bioavailability of dipyridamole, a poorly soluble weak base, was evaluated in 11 healthy, older subjects (> or = 65 years), 6 with a low fasting gastric pH (control) and 5 with a fasting gastric pH > 5 (achlorhydric), in a randomized, crossover d
Publikováno v:
PT : a peer-reviewed journal for formulary management. 36(7)
The prevalence of gastroesophageal reflux disease (GERD) continues to rise, placing an increasing burden on our health care system. Proton pump inhibitors (PPIs) are the most effective and widely used therapy for GERD. Many PPIs are now available in
Autor:
Jennifer B. Dressman, Sahar Z. Swidan, Christos Reppas, Jeffrey L. Barnett, Paul F. Thill, Tobey Stephen W, Rosemary R. Berardi, Dan DuRoss, Constance H. Adair
Publikováno v:
Diabetes Research and Clinical Practice. 22:61-69
The ability of high viscosity hydroxypropylmethylcellulose (HPMC) to reduce postprandial glucose concentrations was assessed in patients with non-insulin-dependent diabetes (NIDDM) and healthy volunteers. The study design consisted of a two-way cross